Drawing for EVIDENCE-DRIVEN ADVOCACY

USPTO serial 78569489

EVIDENCE-DRIVEN ADVOCACY

Reviewed by CopyMark Law Group

Reg. 3110726Status 710
Filing date
Status date
Registration date
Jun 27, 2006
Examiner
BRADLEY, EVELYN
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EVIDENCE-DRIVEN ADVOCACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amie Peele Carter

AMIE PEELE CARTER BAKER & DANIELS LLP300 N MERIDIAN STINDIANAPOLIS, IN 46204UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Providing business marketing information on products in the fields of health care and medical technology; preparing promotional materials for others; business consulting services, namely, business and pricing strategy development for others, product positioning and market research in the fields of health care and medical technology; preparing business reports for others in the fields of health care and medical technology for submission to investors and capital venture companies for the purpose of obtaining investments; lobbying, namely, promoting legislative and regulatory interests of businesses in the field of health care and medical technology; grass root advocacy, namely, promoting the interests of businesses in the field of health care and medical technology; developing promotional campaigns for businesses in the field of health care and medical technology; business services, namely, non-legal representation of others before the United States Food and Drug Administration and centers for Medicare and Medicaid; business services, namely, representing others in trade associations in the fields of health care and medical technology; business consultation relating to complaint resolution, product failure investigations and crisis management in the fields of health care and medical technology; facilitating technology transfer for others, namely, providing business advice in the field of technology transfer; conducting due diligence and compliance audits for others, namely, conducting due diligence and compliance audits relating to business oversight and business mergers in the fields of health care and medical technologySECTION 8 - CANCELLEDMar 17, 2006
042Consultation relating to compliance with health care and medical technology regulations; product research and development in the field of health care and medical technology; development and assessment of quality control systems for others in the field of health and medical technology; development and assessment of clinical trials for others in the field of health care and medical technology; drafting legislation and regulations for others in the fields of health care and medical technology; tracking legislation and regulations for others in the fields of health care and medical technologySECTION 8 - CANCELLEDMar 17, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 1, 2013C8..CANCELLED SEC. 8 (6-YR)—
Nov 16, 2006C.7CNEW CERTIFICATE UNDER SECTION 7 - PROCESSED—
Oct 31, 2006PLGLASSIGNED TO PARALEGAL—
Jul 17, 2006AMD7SEC 7 REQUEST FILED—
Jul 17, 2006MAILPAPER RECEIVED—
Jun 28, 2006ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 27, 2006R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
May 12, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 28, 2006ALIEASSIGNED TO LIE—
Apr 26, 2006CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Apr 26, 2006IUAAUSE AMENDMENT ACCEPTED—
Apr 6, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 6, 2006AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Mar 17, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2006IUAFUSE AMENDMENT FILED—
Mar 17, 2006EAAUTEAS AMENDMENT OF USE RECEIVED—
Mar 17, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2005DOCKASSIGNED TO EXAMINER—
Mar 1, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance